Brief: Aptose Biosciences Inc Reports Quarterly Loss Per Share Of $0.11
23/03/2023 21:39
March 23 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE REPORTS RESULTS FOR THE FOURTH QUARTER AND FULL
YEAR 2022
* APTOSE BIOSCIENCES INC QTRLY LOSS PER SHARE $0.11
* APTOSE BIOSCIENCES INC- EXPECTS CASH ON HAND TO BE
SUFFICIENT TO
FUND PLANNED OPERATIONS INCLUDING RESEARCH AND DEVELOPMENT INTO
Q1 OF 2024
Source text for Eikon: ID:nGNX2pLnzl
Further company coverage: APS.TO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting